Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 10-1987 | 07-1987 | 04-1987 | 01-1987 | 10-1986 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 487 | 373 | 493 | 141 | 259 |
| TOTAL | $487 | $373 | $493 | $141 | $259 |
| Non-Current Assets | |||||
| PPE Net | 6,653 | 6,598 | 6,249 | 5,937 | 4,283 |
| Other Non-Current Assets | 6,265 | 6,376 | 6,478 | 6,543 | 6,588 |
| TOTAL | $12,918 | $12,974 | $12,727 | $12,480 | $10,871 |
| Total Assets | $13,405 | $13,347 | $13,220 | $12,621 | $11,130 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 102 | 2,073 | 2,088 | 2,091 | 2,128 |
| Accounts payable and accrued liabilities | 3,149 | 3,133 | 3,973 | 3,306 | 3,102 |
| Accrued Expenses | 1,462 | 1,572 | 1,142 | 1,412 | 1,172 |
| TOTAL | $5,857 | $7,835 | $8,017 | $8,235 | $7,459 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 609 | 426 | 437 | 334 | 337 |
| TOTAL | $1,045 | $924 | $891 | $745 | $713 |
| Total Liabilities | $6,902 | $8,759 | $8,908 | $8,980 | $8,172 |
| Shareholders' Equity | |||||
| Common Shares | 30 | 30 | 30 | 30 | 30 |
| Other shareholders' equity | -377 | -95 | -51 | -88 | -106 |
| TOTAL | $10,282 | $10,564 | $10,608 | $10,571 | $10,553 |
| Total Liabilities And Equity | $17,184 | $19,323 | $19,516 | $19,551 | $18,725 |